Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 10
- +3 vs. Q1 2026
- Portfolio value
- $1.85M
- −$2.17M (−53.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPCXSpace Exploration Technologies Corp | CLASS A COM STK | 2,606 | $445.3K | 24.0% | +2,606 | New | History |
| BRK.BBerkshire Hathaway Inc | Stock | 754 | $377.1K | 20.3% | +27+3.7% | Added | History |
| GOOGLAlphabet Inc. | Stock | 691 | $246.9K | 13.3% | +691 | New | History |
| Vanguard S&P 500 ETF922908363 | ETF | 339 | $233.1K | 12.6% | +339 | New | – |
| BXBlackstone Inc. | COM | 1,597 | $188.2K | 10.2% | +1,597 | New | History |
| KYTXKyverna Therapeutics, Inc. | COM | 12,347 | $110.0K | 5.9% | −6,426−34.2% | Reduced | History |
| LXEOLexeo Therapeutics, Inc. | COM | 16,962 | $79.0K | 4.3% | +3,019+21.7% | Added | History |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 15,557 | $72.7K | 3.9% | 00.0% | Unchanged | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 28,453 | $57.8K | 3.1% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 20,946 | $43.4K | 2.3% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.